Alnylam Pharmace. buy Royal Bank of Canada
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Alnylam Pharmace. has seen massive gains of 75.55%. This prediction currently runs until 20.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Alnylam Pharmace. | 0.123% | 0.123% |
iShares Core DAX® | 1.665% | 1.692% |
iShares Nasdaq 100 | -0.475% | 1.483% |
iShares Nikkei 225® | 2.620% | 4.475% |
iShares S&P 500 | -0.091% | 1.099% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Alnylam Pharmace. diskutieren
Stopped prediction by Royal_Bank_of_Canada for Alnylam Pharmace.
Alnylam Pharmace.
02.08.24
02.08.25
26.08.24
Alnylam Pharmace.
25.06.24
25.06.25
26.08.24
Alnylam Pharmace.
14.02.24
14.02.25
26.08.24
Alnylam Pharmace.
03.11.23
03.11.24
26.08.24
Alnylam Pharmace.
06.10.23
06.10.24
26.08.24
Alnylam Pharmace.
12.09.23
12.09.24
26.08.24
Alnylam Pharmace.
28.08.23
28.08.24
26.08.24
Alnylam Pharmace.
18.08.23
18.08.24
19.08.24
Alnylam Pharmace.
04.08.23
04.08.24
05.08.24
Alnylam Pharmace.
25.07.23
25.07.24
26.07.24